Skip Navigation

A Phase II Study of Combining T-VEC NSC-785349 and Pembrolizumab NSC-776864 in Patients with Advanced Melanoma Who Have Progressed on Anti-PD1/L1 Based Therapy

Brief Summary

Type:
Melanoma

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT02965716

Study #:
STUDY00141870

Start Date:
Jan 01, 0001

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02965716

View Complete Trial Details & Eligibility at ClinicalTrials.gov